Dr. Jose Vargas, MD (he/him) is an Endocrinologist, Internist in Birmingham, AL with over 15 years of experience. What is your opinion of Dr. Jose Vargas, MD? Rate this provider below so other people can make informed decision.
Over 15 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Jose Vargas, MD has received over $326,155 which includes payments from the following companies:
$129,296.81 from Amarin Pharma Inc.
$92,257.50 from Boehringer Ingelheim Pharmaceuticals, Inc.
$44,846.59 from AstraZeneca Pharmaceuticals LP
$26,972.06 from Merck Sharp & Dohme Corporation
$20,195.98 from LILLY USA, LLC
$3,141.05 from Janssen Pharmaceuticals, Inc
$2,220.88 from Medtronic MiniMed, Inc.
$1,147.73 from Novo Nordisk Inc
$926.66 from sanofi-aventis U.S. LLC
$662.95 from Corcept Therapeutics
$573.48 from Abbott Laboratories
$544.68 from Kowa Pharmaceuticals America, Inc.
$485.30 from Amgen Inc.
$459.17 from AbbVie, Inc.
$359.92 from GlaxoSmithKline, LLC.
$302.64 from Allergan Inc.
$289.38 from Animas Corporation
$166.94 from Novartis Pharmaceuticals Corporation
$121.78 from Eisai Inc.
$104.09 from Janssen Scientific Affairs, LLC
Payments received by Dr. Jose Vargas, MD were from the following categories:
$242,857.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!